What is SynDevRx worth?
$120.0Mlast known valuation
SynDevRx last raised $6.5M in its Debt (Nov 2024).
Free account
See the evidence behind this price
- ·Post-money valuations for all 6 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for SynDevRx
Create free account
No card required
Funding history
6 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Nov 2024 | Debt | $6.5M | ▮ | ▮ |
| Sep 2024 | Early Stage VC | $29.4M | ▮ | ▮ |
| Jan 2020 | Debt | $23.2M | ▮ | ▮ |
| Mar 2018 | Seed Round | $850K | ▮ | ▮ |
| Aug 2017 | Debt | $1.5M | ▮ | ▮ |
| Oct 2012 | Debt | $16.3M | ▮ | ▮ |
How SynDevRx's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For SynDevRx, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is SynDevRx worth?
- SynDevRx's last known valuation is $120.0M.
- How much has SynDevRx raised?
- SynDevRx has raised $93.8M in total funding across 6 recorded rounds.
- When did SynDevRx last raise?
- SynDevRx last raised in Nov 2024 (Debt), raising $6.5M.